Skip to main content
. 2023 Mar 21;24(6):5933. doi: 10.3390/ijms24065933

Figure 5.

Figure 5

Eupatilin inhibits β-catenin signalling pathway. (A) Relative mRNA expression of β-catenin in LX-2 cells treated with eupatilin (mean ± SD, n = 3). (B) Western blot analysis of β-catenin in LX-2 cells treated with eupatilin. (C) Relative protein signal intensity of Figure 5B was quantified as mean ± standard deviation (mean ± SD, n = 3). (D) Western blot analysis of β-catenin protein in both cytoplasm and nucleus. (E) Relative protein signal intensity of Figure 5D was quantified as mean ± standard deviation (mean ± SD, n = 3). The mRNA and proteins detection were preformed 48 h after eupatilin treatment. p values are calculated by one-way ANOVA followed by the Tukey’s test. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. 0 μM EUP group. EUP: Eupatilin; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.